Pediatrics
Maternal oral microbiota plays a key role in influencing infant gut health and disease risk.
Breastfeeding and Bifidobacterium are key factors in shaping the infant resistome and could offer strategies to reduce antibiotic resistance early in life.
Specific gut bacteria are important in early life for healthy immune development.
Bacterial metabolites such as inosine could be used as a therapy to strengthen infant immunity after early microbiota disruption.
Professor Roberto Berni Canani, pediatrician at the University of Naples Federico II, previews the key topics he will present at the 10th International Congress of Probiotics, Prebiotics and Postbiotics in…
Professor Flavia Indrio, President of the 10th International Congress on Probiotics, Prebiotics, and Postbiotics in Pediatrics, previews the key topics for the upcoming 2026 event in Lecce, April 16-18.
A microbiota-mediated macrophage-dependent mechanism may be used to reduce diabetes incidence in vivo.
The findings of a recent study highlight the importance of early-life gut microbes in shaping lung health and add to evidence that microbiota composition can influence asthma risk.
The gut microbiota evolves throughout early life, especially during key transitions phases such as weaning.
Researchers have developed new tools to better understand the role of Bifidobacterium breve, revealing its competitive growth strategies and potential for supporting the immune system.
